These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4009060)

  • 1. De novo sterologenesis in the skin. II. Regulation by cutaneous barrier requirements.
    Menon GK; Feingold KR; Moser AH; Brown BE; Elias PM
    J Lipid Res; 1985 Apr; 26(4):418-27. PubMed ID: 4009060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of essential fatty acid deficiency on cutaneous sterol synthesis.
    Feingold KR; Brown BE; Lear SR; Moser AH; Elias PM
    J Invest Dermatol; 1986 Nov; 87(5):588-91. PubMed ID: 3772153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of epidermal lipogenesis to cutaneous barrier function.
    Grubauer G; Feingold KR; Elias PM
    J Lipid Res; 1987 Jun; 28(6):746-52. PubMed ID: 3611976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of de novo sterologenesis in mammalian skin.
    Feingold KR; Brown BE; Lear SR; Moser AH; Elias PM
    J Invest Dermatol; 1983 Oct; 81(4):365-9. PubMed ID: 6619567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of vitamin D status on cutaneous sterologenesis in vivo and in vitro.
    Feingold KR; Williams ML; Pillai S; Menon GK; Halloran BP; Bikle DD; Elias PM
    Biochim Biophys Acta; 1987 Sep; 930(2):193-200. PubMed ID: 3040120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo sterologenesis in the intact rat.
    Feingold KR; Wiley MH; MacRae G; Lear S; Moser AH; Zsigmond G; Siperstein MD
    Metabolism; 1983 Jan; 32(1):75-81. PubMed ID: 6848899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo sterologenesis in intact primates.
    Feingold KR; Wiley MH; Moser AH; Lau DT; Lear SR; Siperstein MD
    J Lab Clin Med; 1982 Sep; 100(3):405-10. PubMed ID: 6809874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors.
    Tsai JC; Guy RH; Thornfeldt CR; Gao WN; Feingold KR; Elias PM
    J Pharm Sci; 1996 Jun; 85(6):643-8. PubMed ID: 8773963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous permeability barrier repair following various types of insults: kinetics and effects of occlusion.
    Taljebini M; Warren R; Mao-Oiang M; Lane E; Elias PM; Feingold KR
    Skin Pharmacol; 1996; 9(2):111-9. PubMed ID: 8722605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical mevalonic acid stimulates de novo cholesterol synthesis and epidermal permeability barrier homeostasis in aged mice.
    Haratake A; Ikenaga K; Katoh N; Uchiwa H; Hirano S; Yasuno H
    J Invest Dermatol; 2000 Feb; 114(2):247-52. PubMed ID: 10651982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ichthyosis induced by cholesterol-lowering drugs. Implications for epidermal cholesterol homeostasis.
    Williams ML; Feingold KR; Grubauer G; Elias PM
    Arch Dermatol; 1987 Nov; 123(11):1535-8. PubMed ID: 3674913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of altered serum cholesterol levels and fasting on cutaneous cholesterol synthesis.
    Wu-Pong S; Elias PM; Feingold KR
    J Invest Dermatol; 1994 May; 102(5):799-802. PubMed ID: 8176266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cholesterol feeding and alterations in bile acid homeostasis on de novo sterologenesis in diabetic rats.
    Feingold KR; Wiley MH; Moser AH; Lear SR
    Diabetes; 1983 Apr; 32(4):368-76. PubMed ID: 6832491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin.
    Man MQ; Feingold KR; Elias PM
    Arch Dermatol; 1993 Jun; 129(6):728-38. PubMed ID: 8507075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulation of epidermal lipid synthesis by permeability barrier requirements.
    Feingold KR
    Crit Rev Ther Drug Carrier Syst; 1991; 8(3):193-210. PubMed ID: 1954650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrier function regulates epidermal lipid and DNA synthesis.
    Proksch E; Holleran WM; Menon GK; Elias PM; Feingold KR
    Br J Dermatol; 1993 May; 128(5):473-82. PubMed ID: 8504036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased epidermal lipid synthesis accounts for altered barrier function in aged mice.
    Ghadially R; Brown BE; Hanley K; Reed JT; Feingold KR; Elias PM
    J Invest Dermatol; 1996 May; 106(5):1064-9. PubMed ID: 8618040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization and regulation of epidermal 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity by barrier requirements.
    Proksch E; Elias PM; Feingold KR
    Biochim Biophys Acta; 1991 Apr; 1083(1):71-9. PubMed ID: 2031940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High transepidermal water loss induces fatty acid synthesis and cutaneous fatty acid-binding protein expression in rat skin.
    Yamaguchi H; Yamamoto A; Watanabe R; Uchiyama N; Fujii H; Ono T; Ito M
    J Dermatol Sci; 1998 Jul; 17(3):205-13. PubMed ID: 9697049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin barrier disruption by acetone: observations in a hairless mouse skin model.
    Rissmann R; Oudshoorn MH; Hennink WE; Ponec M; Bouwstra JA
    Arch Dermatol Res; 2009 Sep; 301(8):609-13. PubMed ID: 19350255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.